1. Home
  2. VYGR vs IVR Comparison

VYGR vs IVR Comparison

Compare VYGR & IVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • IVR
  • Stock Information
  • Founded
  • VYGR 2013
  • IVR 2008
  • Country
  • VYGR United States
  • IVR United States
  • Employees
  • VYGR N/A
  • IVR N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • IVR Real Estate Investment Trusts
  • Sector
  • VYGR Health Care
  • IVR Real Estate
  • Exchange
  • VYGR Nasdaq
  • IVR Nasdaq
  • Market Cap
  • VYGR 386.1M
  • IVR 472.5M
  • IPO Year
  • VYGR 2015
  • IVR 2009
  • Fundamental
  • Price
  • VYGR $8.01
  • IVR $8.74
  • Analyst Decision
  • VYGR Strong Buy
  • IVR Buy
  • Analyst Count
  • VYGR 7
  • IVR 4
  • Target Price
  • VYGR $17.43
  • IVR $8.00
  • AVG Volume (30 Days)
  • VYGR 624.3K
  • IVR 1.5M
  • Earning Date
  • VYGR 11-04-2024
  • IVR 11-04-2024
  • Dividend Yield
  • VYGR N/A
  • IVR 18.30%
  • EPS Growth
  • VYGR N/A
  • IVR N/A
  • EPS
  • VYGR 0.18
  • IVR N/A
  • Revenue
  • VYGR $143,769,000.00
  • IVR N/A
  • Revenue This Year
  • VYGR N/A
  • IVR N/A
  • Revenue Next Year
  • VYGR N/A
  • IVR N/A
  • P/E Ratio
  • VYGR $45.10
  • IVR N/A
  • Revenue Growth
  • VYGR N/A
  • IVR N/A
  • 52 Week Low
  • VYGR $5.71
  • IVR $6.34
  • 52 Week High
  • VYGR $11.72
  • IVR $9.97
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 68.06
  • IVR 47.31
  • Support Level
  • VYGR $6.78
  • IVR $8.33
  • Resistance Level
  • VYGR $8.17
  • IVR $8.53
  • Average True Range (ATR)
  • VYGR 0.44
  • IVR 0.16
  • MACD
  • VYGR 0.19
  • IVR -0.02
  • Stochastic Oscillator
  • VYGR 93.50
  • IVR 37.61

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About IVR INVESCO MORTGAGE CAPITAL INC

Invesco Mortgage Capital Inc is a REIT that invests, finances, and manages residential and commercial mortgage-backed securities and mortgage loans. The company's portfolio consists of residential mortgage-backed securities (RMBS) that are guaranteed by a U.S. government agency such as the Government National Mortgage Association, or a federally chartered corporation such as the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation; Commercial mortgage-backed securities (CMBS) that are not guaranteed by a U.S. government agency or a federally chartered corporation; RMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation; and other real estate-related financing arrangements.

Share on Social Networks: